Literature DB >> 28780606

Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.

Maria Grazia Zizzo1,2, Rosa Serio3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28780606     DOI： 10.1007/s10620-017-4709-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.

Authors:  Surbhi Aggarwal; Vineet Ahuja; Jaishree Paul
Journal:  Dig Dis Sci       Date:  2017-06-30       Impact factor: 3.199

2.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 3.  The GABAergic System and the Gastrointestinal Physiopathology.

Authors:  Michelangelo Auteri; Maria Grazia Zizzo; Rosa Serio
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116
  3 in total
  1 in total

1.  Anti-inflammatory effect of pregabalin on acetic acid-induced colitis in the rats.

Authors:  Azadeh Motavallian; Ehsan Zamani; Saba Bouzari; Farzam Rezaeyan; Paridokht Karimian; Mehdi Evazalipour
Journal:  Res Pharm Sci       Date:  2021-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.